Merit Medical Systems (NASDAQ:MMSI) has received FDA approval for its WRAPSODY Cell-Impermeable Endoprosthesis device for the treatment of dialysis patients.

The device is designed to extend long-term vessel patency and preserve vascular access in dialysis patients. Merit plans to begin commercializing